About 1 Trademarks found for “LAZERTINIB LOGO (COLOUR)”

Filters

2055525
ADVERTISED

on 18 Sep 2024

LAZERTINIB LOGO (COLOUR)

JOHNSON & JOHNSON

2055525 · 02 Oct 2020

005

Human pharmaceuticals for the treatment of oncologic diseases

Country

Canada

CA

Status

All

Registered

Pending

Abandoned

Other

Owners

Johnson & johnson (1)

Categories

Class 5 (1)

Correspondents

Gowling wlg (canada) llp (1)

End of search results

Page 1 of 1